Targeted Delivery
Liposomal Technology
PlexoZome® is a scientifically proven complex liposomal technology. Our genuine liposomes are verified through TEM and Cryo-TEM imaging, Zeta potential and DLS testing. PlexoZome® formulations are made on site in our licensed facility, as such they are fully customisable stable liposomal ingredients.
PlexoZome® advantages
targeted delivery
scientifically validated genuine liposomes through TEM and Cryo-TEM imaging
fully customisable particle size, with DLS testing
improved stability, verified with Zeta Potential testing
supplied ready to use
Australian developed and made
PlexoZome® Curcumin modulates the synergistic role of EpCAM and estrogen receptor alpha.
This study delves into the in vitro potential of liposomal therapeutics utilising PlexoZome® Curcumin in targeting EpCAM/TROP1 and Estrogen Receptor Alpha (ERα) signalling pathways for LC management.
PlexoZome® is a trademark owned exclusively by Pharmako Biotechnologies Pty. Ltd., registered in Australia and other countries.